156 related articles for article (PubMed ID: 33214609)
21. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A.
Xu BH; Li XX; Yang Y; Zhang MY; Rao HL; Wang HY; Zheng XF
Oncotarget; 2015 Aug; 6(25):20813-28. PubMed ID: 26308575
[TBL] [Abstract][Full Text] [Related]
22. Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer.
Zhang H; Zhong H; Li L; Ji W; Zhang X
Mol Med Rep; 2016 Mar; 13(3):2696-700. PubMed ID: 26861549
[TBL] [Abstract][Full Text] [Related]
23. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
24. Pooled analysis of prognostic value and clinical significance of Rab1A expression in human solid tumors.
Shao X; Cheng Z; Xu M; Tan Z; Gao L; Wang J; Zhou C
Medicine (Baltimore); 2019 Dec; 98(50):e18370. PubMed ID: 31852145
[TBL] [Abstract][Full Text] [Related]
25. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
26. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
[TBL] [Abstract][Full Text] [Related]
27. TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.
Zheng S; Zhou C; Wang Y; Li H; Sun Y; Shen Z
J Exp Clin Cancer Res; 2020 Jan; 39(1):23. PubMed ID: 31992359
[TBL] [Abstract][Full Text] [Related]
28. FOXM1 promotes invasion and migration of colorectal cancer cells partially dependent on HSPA5 transactivation.
Luo X; Yao J; Nie P; Yang Z; Feng H; Chen P; Shi X; Zou Z
Oncotarget; 2016 May; 7(18):26480-95. PubMed ID: 27034162
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of FOXM1 and Gli-1 protein expression in high-grade ovarian serous carcinoma].
Zhang J; Li ZY; Duan XJ; Fan XM; Liu WN; Li YH
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):904-908. PubMed ID: 27998466
[No Abstract] [Full Text] [Related]
30. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer.
Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A
Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520
[TBL] [Abstract][Full Text] [Related]
31. FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer.
Breyer J; Wirtz RM; Erben P; Rinaldetti S; Worst TS; Stoehr R; Eckstein M; Sikic D; Denzinger S; Burger M; Hartmann A; Otto W
BJU Int; 2019 Jan; 123(1):187-196. PubMed ID: 30120861
[TBL] [Abstract][Full Text] [Related]
32. ENO1 Acts as a Prognostic Biomarker Candidate and Promotes Tumor Growth and Migration Ability Through the Regulation of Rab1A in Colorectal Cancer.
Cheng Z; Shao X; Xu M; Zhou C; Wang J
Cancer Manag Res; 2019; 11():9969-9978. PubMed ID: 32063722
[TBL] [Abstract][Full Text] [Related]
33. AKT1 phosphorylates RBM17 to promote Sox2 transcription by modulating alternative splicing of FOXM1 to enhance cancer stem cell properties in colorectal cancer cells.
Fu Y; Bai C; Wang S; Chen D; Zhang P; Wei H; Rong F; Zhang C; Chen S; Wang Z
FASEB J; 2023 Jan; 37(1):e22707. PubMed ID: 36520054
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.
Li L; Wu D; Yu Q; Li L; Wu P
Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178
[TBL] [Abstract][Full Text] [Related]
35. TRIM24 aggravates the progression of ovarian cancer through negatively regulating FOXM1 level.
Zhou HE; Pan SS; Han H
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10647-10656. PubMed ID: 31858531
[TBL] [Abstract][Full Text] [Related]
36. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Shang R; Pu M; Li Y; Wang D
Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.
Yu M; Tang Z; Meng F; Tai M; Zhang J; Wang R; Liu C; Wu Q
Tumour Biol; 2016 Jan; 37(1):1289-97. PubMed ID: 26289845
[TBL] [Abstract][Full Text] [Related]
38. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer.
Yang XZ; Cui SZ; Zeng LS; Cheng TT; Li XX; Chi J; Wang R; Zheng XF; Wang HY
Aging (Albany NY); 2017 Mar; 9(3):914-931. PubMed ID: 28316326
[TBL] [Abstract][Full Text] [Related]
40. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]